Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ARG2 | P78540 | 2/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4066708 | 0.85 | — | — | |
| Ethylene Glycol SCHEMBL3135918 | 0.84 | ANPEP (0.50) | TSHRANPEPARG2ARG1 | |
| SCHEMBL2604622 | 0.82 | — | — | |
| SCHEMBL18028388 | 0.75 | — | — | |
| Boric Acid SCHEMBL449392 | 0.75 | — | — | |
| SCHEMBL3956288 | 0.72 | — | — | |
| Boric Acid SCHEMBL19462803 | 0.70 | — | — | |
| Boric Acid SCHEMBL28119482 | 0.70 | TSHR (0.56) | TSHR | |
| Boric Acid SCHEMBL1053215 | 0.70 | TSHR (0.56) | TSHR | |
| Boric Acid SCHEMBL27450158 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118994216-A | 2-Boron ester-norbornene and use thereof and polymer containing alkenyl boron ester in main chain | 北京大学 | 2024-11-22 | — | — | CN | claimed |
| EP-1837373-B1 | RESIN COMPOSITION AND FILM MADE OF SAME | KURARAY CO (JP) | 2019-03-13 | — | — | EP | disclosed |
| WO-2012119117-A1 | VESICLE COMPOSITIONS | SENSULIN, LLC (US) | 2012-09-07 | — | — | WO | disclosed |
| EP-1952979-B1 | MULTILAYER STRUCTURE AND PROCESS FOR PRODUCING THE SAME | KURARAY CO (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-8211541-B2 | Layer of thermoplastic adhesive layer and layer of another polymer; coextrusion molding | KURARAY CO., LTD. (JP) | 2012-07-03 | — | — | US | disclosed |
| US-8084536-B2 | Resin composition and film made of same | KURARAY CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-7968752-B2 | Hydrolytically-resistant boron-containing therapeutics and methods of use | ANACOR PHARMACEUTICALS, INC. (US) | 2011-06-28 | — | — | US | disclosed |
| EP-2123451-B1 | MULTILAYER STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | KURARAY CO (JP) | 2011-03-09 | — | — | EP | disclosed |
| US-20110045314-A1 | MULTILAYER STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | KURARAY CO., LTD. (JP) | 2011-02-24 | — | — | US | disclosed |
| US-20100119746-A1 | RESIN COMPOSITION AND MULTILAYER STRUCTURE | KURARAY CO., LTD. (JP) | 2010-05-13 | — | — | US | disclosed |
| WO-2005013892-A9 | HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE | ANACOR PHARMACEUTICALS INC (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050054644-A1 | Hydrolytically-resistant boron-containing therapeutics and methods of use | ANACOR PHARMACEUTICALS, LLC | 2005-03-10 | — | — | US | disclosed |
| WO-2005013892-A2 | HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20040220366-A1 | Block copolymer and thermoplastic resin composition | KURARAY CO., LTD. (JP) | 2004-11-04 | — | — | US | disclosed |
| US-20040076780-A1 | Method of producing a shaped article having excellent barrier properties | KURARAY CO. LTD (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1369438-A1 | BLOCK COPOLYMER AND THERMOPLASTIC RESIN COMPOSITION | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-20020176955-A1 | Fuel container having excellent gasoline barrier properties | EVAL COMPANY OF AMERICA | 2002-11-28 | — | — | US | disclosed |
| US-20020172788-A1 | Method of producing a shaped article having excellent barrier properties | KURARAY CO., LTD. (JP) | 2002-11-21 | — | — | US | disclosed |
| EP-1245381-A1 | Fuel container having excellent gasoline barrier properties | Kuraray Co., Ltd. (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1166892-A2 | A method of producing a shaped article having excellent barrier properties | Kuraray Co., Ltd. (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054644-A1 | Hydrolytically-resistant boron-containing therapeutics and methods of use | BTD, GAA, GBA3 | TSHR 3617/4885ANPEP 290/4885ARG2 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.